Riley Wyberg

ID: 1b826635-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

FDA Approves Bio-Thera and Hikma’s Ustekinumab Biosimilar

Big Molecule Watch · May 29, 2025

District of New Jersey Denies Preliminary Injunction in Ustekinumab Breach of Contract Case

Big Molecule Watch · May 2, 2025

FDA Approves Fresenius’s Denosumab Biosimilars

Big Molecule Watch · March 27, 2025

FDA Accepts BLA for Alvotech and Dr. Reddy’s Denosumab Biosimilars

Big Molecule Watch · March 20, 2025

Celltrion Launches STEQEYMA® (ustekinumab-stba) in the United States

Big Molecule Watch · March 19, 2025